Literature DB >> 15317873

Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.

Francisco J Sánchez-Gómez1, Eva Cernuda-Morollón, Konstantinos Stamatakis, Dolores Pérez-Sala.   

Abstract

The cyclopentenone prostaglandin and PPARgamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) displays anti-inflammatory effects in several experimental models. Direct modification of protein thiols is arising as an important mechanism of cyclopentenone prostaglandin action. However, little is known about the extent or specificity of this process. Mesangial cells (MC) play a key role in glomerulonephritis. In this work, we have studied the selectivity of protein modification by 15d-PGJ(2) in MC, and the correlation with the modulation of several proinflammatory genes. MC incubation with biotinylated 15d-PGJ(2) results in the labeling of a distinct set of proteins as evidenced by two-dimensional electrophoresis. 15d-PGJ(2) binds to nuclear and cytosolic targets as detected by fluorescence microscopy and subcellular fractionation. The pattern of biotinylated 15d-PGJ(2)-modified polypeptides is readily distinguishable from that of total protein staining or labeling with biotinylated iodoacetamide. 15d-PGJ(2) addition requires the double bond in the cyclopentane ring. 9,10-Dihydro-15d-PGJ(2), a 15d-PGJ(2) analog that shows the same potency as peroxisome proliferator-activated receptor (PPAR) agonist in MC but lacks the cyclopentenone moiety, displays reduced ability to modify proteins and to block 15d-PGJ(2) binding. Micromolar concentrations of 15d-PGJ(2) inhibit cytokine-elicited levels of inducible nitricoxide synthase, cyclooxygenase-2, and intercellular adhesion molecule-1 in MC. In contrast, 9,10-dihydro-15d-PGJ(2) does not reproduce this inhibition. 15d-PGJ(2) effect is not blocked by the PPARgamma antagonist 2-chloro-5-nitro-N-phenylbenzamide (GW9662). Moreover, compounds possessing an alpha,beta-unsaturated carbonyl group, like 2-cyclopenten-1-one and 2-cyclohexen-1-one, reduce pro-inflammatory gene expression. These observations indicate that covalent modification of cellular thiols by 15d-PGJ(2) is a selective process that plays an important role in the inhibition of MC responses to pro-inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317873     DOI: 10.1124/mol.104.002824

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Asoka Banno; Raju C Reddy
Journal:  ACS Chem Biol       Date:  2018-11-29       Impact factor: 5.100

2.  COX2-derived primary and cyclopentenone prostaglandins are increased after asphyxial cardiac arrest.

Authors:  Hao Liu; Marie E Rose; Tricia M Miller; Wenjin Li; Sunita N Shinde; Alicia M Pickrell; Samuel M Poloyac; Steven H Graham; Robert W Hickey
Journal:  Brain Res       Date:  2013-04-24       Impact factor: 3.252

3.  Protein disulfide isomerase as a novel target for cyclopentenone prostaglandins: implications for hypoxic ischemic injury.

Authors:  Hao Liu; Jie Chen; Wenjin Li; Marie E Rose; Sunita N Shinde; Manimalha Balasubramani; Guy T Uechi; Bülent Mutus; Steven H Graham; Robert W Hickey
Journal:  FEBS J       Date:  2015-03-27       Impact factor: 5.542

Review 4.  Basic principles and emerging concepts in the redox control of transcription factors.

Authors:  Regina Brigelius-Flohé; Leopold Flohé
Journal:  Antioxid Redox Signal       Date:  2011-04-05       Impact factor: 8.401

Review 5.  Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium.

Authors:  J W Zmijewski; A Landar; N Watanabe; D A Dickinson; N Noguchi; V M Darley-Usmar
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

6.  Methods for imaging and detecting modification of proteins by reactive lipid species.

Authors:  Ashlee N Higdon; Brian P Dranka; Bradford G Hill; Joo-Yeun Oh; Michelle S Johnson; Aimee Landar; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2009-05-14       Impact factor: 7.376

7.  15-Deoxy-Delta(12,14)-prostaglandin-J(2) reveals a new pVHL-independent, lysosomal-dependent mechanism of HIF-1alpha degradation.

Authors:  Gemma Olmos; María I Arenas; Raquel Bienes; María Jose Calzada; Julián Aragonés; Maria Laura Garcia-Bermejo; Manuel O Landazuri; Javier Lucio-Cazaña
Journal:  Cell Mol Life Sci       Date:  2009-05-21       Impact factor: 9.261

8.  Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377.

Authors:  Guo-Biao Xu; Pei-Pei Guan; Pu Wang
Journal:  Mol Neurobiol       Date:  2020-10-23       Impact factor: 5.590

9.  Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction.

Authors:  Joo Yeun Oh; Niroshini Giles; Aimee Landar; Victor Darley-Usmar
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

10.  15-deoxy-Delta12,14-prostaglandin J2 impairs phosphatidylcholine synthesis and induces nuclear accumulation of thiol-modified cytidylyltransferase.

Authors:  Alan J Ryan; Bill B Chen; Prashanth R Vennalaganti; Florita C Henderson; Linda A Tephly; A Brent Carter; Rama K Mallampalli
Journal:  J Biol Chem       Date:  2008-07-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.